Skip to Content

COVONIA VAPOUR DROPS

Active substance: PEPPERMINT OIL

View full screen / Print PDF » Download PDF ⇩
Transcript
2.  efore you use this
B
medicine

Covonia Vapour Drops

FRONT FACE TOP

(menthol, peppermint oil)

 o not use the medicine if you or
D

Important information about Covonia Vapour
Drops
•  his medicine relieves nasal congestion,
T
catarrh and hay fever in adults and children
over 2 years old.

your child have….

•  n allergy to any of the ingredients listed in
A
section 6.
•  r is under 2 years old.
O

Do not use….
• For anyone under 2 years old.

Pregnant or breastfeeding….

Ask your doctor or pharmacist for advice before
using this medicine if you are pregnant, might
be pregnant or are breastfeeding.
Covonia Vapour Drops should not be used in
pregnancy unless the doctor has told you to do
so.

Now read the rest of the leaflet before you
use this medicine. It includes other
information which might be especially
important for you.
•  eep this leaflet. You may need to read it
K
again.
A
•  sk your pharmacist if you need any more
information or advice.
• f any of the side effects gets serious, or if
I
you notice any side effects not listed in this
leaflet, please tell your doctor or pharmacist.

3. How to use this medicine





Avoid contact with the eyes.
Avoid direct contact with the skin.
Do not place directly into the nostrils.
Do not swallow.

If your symptoms persist you should ask your
doctor for advice.

If you swallow some

If you accidentally swallow some, see a doctor
straight away. Take the pack with you to show
which medicine you have swallowed.

4. Possible side effects
Like all medicines, Covonia Vapour Drops can
have side effects, although these don’t affect
everyone.
•  llergic reactions may occur, such as contact
A
dermatitis and local skin irritation.
If you notice this or any other side effect not
included above, stop use and tell your doctor or
pharmacist. They will tell you what to do.

Dosage
Adults and children over 2 years

1. What the medicine is for
Covonia Vapour Drops contain menthol and
peppermint oil which relieve nasal congestion.
The drops relieve the symptoms of catarrh, hay
fever and nasal congestion.

•  prinkle a few drops onto a handkerchief and
S
inhale the vapour as required.

Turn over
23012806

Reporting of side effects

If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. You can
also report side effects directly via the Yellow
Card Scheme at: www.mhra.gov.uk/yellowcard

REVERSE FACE TOP


Do not give to children under 2 years

By reporting side effects you can help provide
more information on the safety of this
medicine.

What the medicine looks like

Covonia Vapour Drops is a clear yellow liquid.
It is supplied in 7.5ml, 15ml and 30ml bottles.

Marketing authorisation holder and
manufacturer

Thornton and Ross Ltd., Huddersfield,
HD7 5QH, UK.

This leaflet was last revised in February 2015
Covonia is a trade mark of Thornton & Ross Ltd

5. Storing this medicine
• Keep it out of the sight and reach of children.
• Do not store above 25°C.
•  o not use after the expiry date shown on the
D
carton. The expiry date refers to the last day
of that month.
•  edicine should not be disposed of via
M
wastewater or household waste. Ask your
pharmacist how to dispose of any unused
MHRA Header Box
medicine. These measures will help to protect
Covonia Vapour Drops
Product
the environment.

Colours Used

Title

6. Further information
Component
Leaflet

Process Black

The active ingredients are:
Pack Size
7.5ml/15ml/30ml
menthol 17.5% w/v, peppermint oil 0.2% v/v.
IG Code
23012806
The other ingredients are:
eucalyptus oil, cajuput oil, spike lavender(27 x 123mm folded)
210 x 123mm flat
Dimensions
fragrance oil, industrial methylated spirit.

Fonts Used

23012806

Helvetica

Print free (Does not print)

Keyline (Does not print)

What is in this medicine

Proof No.

1

Date

02.02.2015

PCP Header Box
Operator

Approved by
Date

gill.kennedy

Artwork No 555333
Suf fix

CRN

11915

Reason for
Change

Addition of reporting of side
effects statement

A

Issued by
Date

MHRA/IMB
submission Yes
required

23012806

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide